SpikeMix™ SARS-CoV-2 - heavy


In stock


About SpikeMix™ SARS-CoV-2 - heavy

Pool of 23 stable isotope-labeled peptides from SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2). Peptide mixture for protein quantification by mass spectrometry based proteomics (e.g. MRM).

SpikeMix™ SARS-CoV-2 - heavy - Specifications

Amount: approx. 100 pmol per peptide
Purity: crude
Delivery Format: Freeze-dried in plastic vial
Application(s): Proteomics
Condition(s)/Topic(s): Covid-19, Infection, Respiratory infection
Standard Delivery Time: 2-5 days

Visit our webpage for more information on SARS-CoV-2, its mutations & variants and our corresponding products.

Are you interested in your custom peptide pools for your proteomics assays? Choose your sequence, amount and label. We will assist you along the way. Custom SpikeMix Reference Pools.

JPT's SpikeMix™
JPT produces specific mixtures of stable isotope-labeled peptides for the detection of relevant proteins by mass-spectrometry based proteomics. The mixed peptides are available as stable isotope labeled peptides (using heavy Arg U-13C6, U-15N4 or Lys U-13C6, U-15N2).

Benefits of JPT's SpikeMix™
- Quantification of multiple proteins from a single sample
- Economic premixed heavy peptide sets
- Multiplexed analysis of disease status and therapeutic success


References for SpikeMix™ SARS-CoV-2 - heavy

Read References with Reference Peptides for Targeted Proteomics - SpikeTides™ & SpikeMix™ & COVID-19 related publications

"As Director of the Protein Profiling at Yale Keck Biotechnology Resource Facility, I coordinated a collaboration between the Association of Biomolecular Resource Facilities (ABRF) standard proteomic research group (sPRG) and JPT Peptide Technologies to develop the ABRF cross-species SpikeMix™ peptide pool. The joint development turned out to be an extraordinary effective endeavor and the resulting product was qualified in more than 52 proteomics labs around the globe. I was impressed by JPT's scientific and technological capabilities as well as their enthusiasm to drive the project forward."
Christopher M. Colangelo, Director of Protein Profiling at Keck Biotechnology Resource Facility, Yale University, USA

"Our research at Stanford University seeks to discover unconventional translation products, and proteins made by unsequenced organisms; to characterize a wide array of protein post-translational modifications; and to perform peptide antigen binding assays. On all of these fronts, we are in need of high quality peptide standards for assay development and protein quantification. The successful collaboration with the team at JPT Peptide Technologies and their wide range of products has been a critical factor for advancing my group's research."
Joshua E. Elias, Ph.D., Assistant Professor, Chemical & Systems Biology, Stanford University School of Medicine, Clark Center, Stanford, CA


Properties of SpikeMix™ SARS-CoV-2 - heavy

Properties Values
Amount: approx. 100 pmol per peptide
Application: Proteomics
Category: SpikeMix™ for Targeted Proteomics
Condition / Topic: Covid-19, Infection, Respiratory infection
Layout: Freeze-dried in plastic vial
Organism: SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Protein Name: Selected proteins
Purity: crude
Quantification: Yes

Further Information to SpikeMix™ SARS-CoV-2 - heavy

Information Values
Sequence: See Product Documentation
Specifications: Mix of stable isotope labeled peptides
TÜV Rheinland certified
Health - made in Germany
Quality Assurance

All production is ISO 9001:2015 certified.

Check our list of products, click and go.

Get a quote